years counting: prospects defeating alzheimers disease 
week marks century since first description alzheimers disease ad despite approval several drugs ad disease continues rob millions memories lives fortunately many new therapies directly targeting mechanisms underlying ad now pipeline among investigative ad therapies clinical trials several strategies block pathogenic amyloid-beta peptides rescue vulnerable neurons degeneration complementary less mature strategies aim prevent copathogenic effects apolipoprotein e microtubule-associated protein tau new insights selective neuronal vulnerability link aging ad may provide additional entry points therapeutic interventions predicted increase ad cases next decades makes development better treatments matter utmost importance urgency 
